Hans van der Vuurst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hans van der Vuurst has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Jan-Willem N. Akkerman
Laboratory for Thrombosis and Haemostasis, Department of Haematology, University Medical Center Utrecht and Institute for Biomembranes, Utrecht University, The Netherlands
4 shared publicationsGijsbert van Willigen
From the Department of Haematology, University Hospital Utrecht, The Netherlands
3 shared publications- Cas Weykamp
Queen Beatrix Hospital, Winterswijk, The Netherlands
2 shared publications - Els Den Dekker
Thrombosis and Haemostasis Laboratory, Department of Haematology, University Medical Center Utrecht, the Netherlands
2 shared publications Gertie Gorter
From the Thrombosis and Haemostasis Laboratory (E.d.D., G.G., H.v.d.V., J.D., C.K., J.-W.N.A.), Department of Haematology, University Medical Center Utrecht and Institute for Biomembranes, Utrecht University, Utrecht, and the Department of Biochemistry and Human Biology (J.W.M.H.), Maastricht University, Maastricht, The Netherlands, and the Department of Molecular Neurobiology (K.M.), Institute of Medical Science, Tokyo University, Tokyo, Japan
2 shared publications- Jan Willem N. Akkerman
From the Thrombosis and Haemostasis Laboratory, DCCH, the Department of Immunology, UMC‐Utrecht, the Institute for Biomembranes Utrecht University, and the Sanquin Blood Bank Region North‐West, Utrecht, the Netherlands; and the Laboratory for Thrombosis Research, IRC, KU Leuven Campus, Kortrijk Belgium
2 shared publications
Latest Publications
- 26 July 2018
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 56 (8) , e185-e187
Glucose and total protein: unacceptable interference on Jaffe creatinine assays in patients
Article Glucose and total protein: unacceptable interference on Jaffe creatinine assays in patients was published on August 1, 2018 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 56, issue 8).
- 26 July 2018
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 56 (8) , e185-e187
Glucose and total protein: unacceptable interference on Jaffe creatinine assays in patients
Article Glucose and total protein: unacceptable interference on Jaffe creatinine assays in patients was published on August 1, 2018 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 56, issue 8).
- 31 January 2011
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 49 (4) , 647-651
Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c
Background: We report an evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser (HA-8180V), the fifth generation Menarini/ARKRAY ion-exchange HPLC for the measurement of HbA1c. Methods: We evaluated the analytical performance, the measurement of haemoglobin variants and the performance in comparison to major analytical methods. Results: Within-run, between-run and total CV were 0.2%, 0.4% and 0.7% at low HbA1c concentrations and 0.2%, 0.2% and 0.4% at high HbA1c concentrations, respectively. Trueness revealed a maximum deviation of 0.8 mmol/mol (IFCC units) or 0.1% (NGSP units) over the relevant analytical range. Linearity, carry-over and linear drift were excellent. Labile-HbA1c, carbamylated haemoglobin, icteric samples and variation in hematocrit did not affect HbA1c outcome. Haemoglobin variants AS, AC and F do not affect HbA1c outcome and are explicitly identified and correctly quantified. HbA1c can not be measured in samples with AE and AD, but these variants are identified correctly. In comparison to other methods used at present, the HA-8180V shows excellent performance. Conclusions: The HA-8180V performs at a high level and is fit for any clinical application.
- 31 January 2011
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 49 (4) , 647-651
Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c
Background: We report an evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser (HA-8180V), the fifth generation Menarini/ARKRAY ion-exchange HPLC for the measurement of HbA1c. Methods: We evaluated the analytical performance, the measurement of haemoglobin variants and the performance in comparison to major analytical methods. Results: Within-run, between-run and total CV were 0.2%, 0.4% and 0.7% at low HbA1c concentrations and 0.2%, 0.2% and 0.4% at high HbA1c concentrations, respectively. Trueness revealed a maximum deviation of 0.8 mmol/mol (IFCC units) or 0.1% (NGSP units) over the relevant analytical range. Linearity, carry-over and linear drift were excellent. Labile-HbA1c, carbamylated haemoglobin, icteric samples and variation in hematocrit did not affect HbA1c outcome. Haemoglobin variants AS, AC and F do not affect HbA1c outcome and are explicitly identified and correctly quantified. HbA1c can not be measured in samples with AE and AD, but these variants are identified correctly. In comparison to other methods used at present, the HA-8180V shows excellent performance. Conclusions: The HA-8180V performs at a high level and is fit for any clinical application.
- 22 October 2003
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1643 (1-3) , 85-94
Cell-to-cell variability in the differentiation program of human megakaryocytes
- 22 October 2003
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1643 (1-3) , 85-94
Cell-to-cell variability in the differentiation program of human megakaryocytes
- 1 January 2002
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (1) , 179-186
Cyclic AMP Raises Intracellular Ca 2+ in Human Megakaryocytes Independent of Protein Kinase A
The immature megakaryoblastic cell line MEG-01 responds to iloprost with an increase in cytosolic Ca 2+ and cAMP. The Ca 2+ response is almost absent in CHRF-288-11 cells, but cAMP formation is preserved in this more mature megakaryoblastic cell line. Also, in human hematopoietic stem cells, iloprost induces a Ca 2+ response and cAMP formation. The Ca 2+ response is downregulated during megakaryocytopoiesis, but cAMP formation remains unchanged. The Ca 2+ increase may be caused by cAMP-mediated inhibition of Ca 2+ sequestration, because it is (1) independent of Ca 2+ entry; (2) mimicked by forskolin, an activator of adenylyl cyclase, and isobutylmethylxanthine, an inhibitor of phosphodiesterases; and (3) preserved in the presence of inhibitors of protein kinase A and inositol-1,4,5-triphosphate receptors. The small GTPase Rap1 has been implicated in the control of Ca 2+ sequestration. Indeed, Rap1 activation parallels the iloprost- and forskolin-induced Ca 2+ increase and is unaffected by the calcium chelator 1,2-bis(2-aminophenoxy)ethane- N , N , N ′, N ′,-tetraacetic acid-AM. These findings reveal a novel mechanism for elevating cytosolic Ca 2+ by cAMP, possibly via GTP-Rap1.
- 1 January 2002
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (1) , 179-186
Cyclic AMP Raises Intracellular Ca 2+ in Human Megakaryocytes Independent of Protein Kinase A
The immature megakaryoblastic cell line MEG-01 responds to iloprost with an increase in cytosolic Ca 2+ and cAMP. The Ca 2+ response is almost absent in CHRF-288-11 cells, but cAMP formation is preserved in this more mature megakaryoblastic cell line. Also, in human hematopoietic stem cells, iloprost induces a Ca 2+ response and cAMP formation. The Ca 2+ response is downregulated during megakaryocytopoiesis, but cAMP formation remains unchanged. The Ca 2+ increase may be caused by cAMP-mediated inhibition of Ca 2+ sequestration, because it is (1) independent of Ca 2+ entry; (2) mimicked by forskolin, an activator of adenylyl cyclase, and isobutylmethylxanthine, an inhibitor of phosphodiesterases; and (3) preserved in the presence of inhibitors of protein kinase A and inositol-1,4,5-triphosphate receptors. The small GTPase Rap1 has been implicated in the control of Ca 2+ sequestration. Indeed, Rap1 activation parallels the iloprost- and forskolin-induced Ca 2+ increase and is unaffected by the calcium chelator 1,2-bis(2-aminophenoxy)ethane- N , N , N ′, N ′,-tetraacetic acid-AM. These findings reveal a novel mechanism for elevating cytosolic Ca 2+ by cAMP, possibly via GTP-Rap1.
- 1 January 2001
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 86 (10) , 1106-1113
Biogenesis of G-protein Mediated Calcium Signaling in Human Megakaryocytes
To understand how platelet signal transduction pathways develop during megakaryocytopoiesis, we isolated human stem cells from umbilical cord blood and cultured the cells in the presence of thrombopoietin (TPO). Based on the early expression of CD61 and late expression of CD42b, immature (CD61+/CD42blow) and mature (CD61+/ CD42bhigh) megakaryocytes were immunomagnetically purified and, together with stem cells (CD34+), characterized for G -protein expression and agonist-induced [Ca2+]i increases. Megakaryocytopoiesis was accompanied by down-regulation of the 43 kDa and 46 kDa variants of G16α, constant expression of Gsα, and up-regulation of Gqα and Giα1/2. The increase in Gq and Gi 1/2 expression was accompanied by an increase in Ca2+ signaling triggered by thrombin and other agonists known to signal to Ca2+ via these G-proteins in platelets. The prostacyclin analog iloprost and TPO also induced [Ca2+]i increases, and the iloprost-induced Ca2+ response disappeared during maturation. These data reveal sharp changes in Ca2+ regulation during megakaryocytopoiesis.
- 1 January 2001
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 86 (10) , 1106-1113
Biogenesis of G-protein Mediated Calcium Signaling in Human Megakaryocytes
To understand how platelet signal transduction pathways develop during megakaryocytopoiesis, we isolated human stem cells from umbilical cord blood and cultured the cells in the presence of thrombopoietin (TPO). Based on the early expression of CD61 and late expression of CD42b, immature (CD61+/CD42blow) and mature (CD61+/ CD42bhigh) megakaryocytes were immunomagnetically purified and, together with stem cells (CD34+), characterized for G -protein expression and agonist-induced [Ca2+]i increases. Megakaryocytopoiesis was accompanied by down-regulation of the 43 kDa and 46 kDa variants of G16α, constant expression of Gsα, and up-regulation of Gqα and Giα1/2. The increase in Gq and Gi 1/2 expression was accompanied by an increase in Ca2+ signaling triggered by thrombin and other agonists known to signal to Ca2+ via these G-proteins in platelets. The prostacyclin analog iloprost and TPO also induced [Ca2+]i increases, and the iloprost-induced Ca2+ response disappeared during maturation. These data reveal sharp changes in Ca2+ regulation during megakaryocytopoiesis.
- 1 May 1998
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 79 (05) , 1014-1020
Maturation of Megakaryoblastic Cells Is Accompanied by Upregulation of GSα-L Subtype and Increased cAMP Accumulation
In platelets and megakaryoblasts Gs, the trimeric G-protein that stimulates adenylyl cyclase, is present in a short, 45 kDa, and a long, 52 kDa isoform termed Gsα-S and Gsα-L, respectively. To assess the relative contribution of these isoforms in the cellular synthesis of cAMP, the ratio Gsα-S/Gsα-L was changed in the megakaryoblastic cell line DAMI by inducing cell maturation with recombinant human thrombopoietin (TPO) or the phorbol ester PMA. Flow cytometric analysis confirmed that this treatment induced a moderate (TPO) and extensive (PMA) increase in nuclear ploidy and expression of the glycoproteins-IIIa and -Ib. Northern blot analysis revealed down-regulation of total GS-mRNA after treatment of DAMI-cells with TPO and PMA. Western blot analysis showed significant (P s-L with respective amounts of 27 ± 4% of total G s in untreated cells, 35 ± 1% in TPO- and 41 ± 3% in PMA-treated DAMI cells (n = 3-4). DAMI cells contained 6 ± 1 pmol cAMP/106 cells, which was not changed by treatment with TPO or PMA. In untreated cells this level increased to 70 ± 9 pmol cAMP/106 cells after 10 min stimulation with 1 μmol/l of the stable prostacyclin analog iloprost. The same stimulation with iloprost resulted in 165 ± 32 pmol cAMP/106 in TPO-treated cells and in 588 ± 100 pmol cAMP/106 in cells treated with PMA. Thus, a shift from Gsα-S to Gsα-L during megakaryoblast maturation strongly potentiates the production of cAMP. A similar shift may occur during normal megakaryocyte maturation and may explain the extreme sensitivity to prostacyclin of platelets, which contain Gsα-S and Gsα-L in approximately equal amounts.
- 1 May 1998
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 79 (05) , 1014-1020
Maturation of Megakaryoblastic Cells Is Accompanied by Upregulation of GSα-L Subtype and Increased cAMP Accumulation
In platelets and megakaryoblasts Gs, the trimeric G-protein that stimulates adenylyl cyclase, is present in a short, 45 kDa, and a long, 52 kDa isoform termed Gsα-S and Gsα-L, respectively. To assess the relative contribution of these isoforms in the cellular synthesis of cAMP, the ratio Gsα-S/Gsα-L was changed in the megakaryoblastic cell line DAMI by inducing cell maturation with recombinant human thrombopoietin (TPO) or the phorbol ester PMA. Flow cytometric analysis confirmed that this treatment induced a moderate (TPO) and extensive (PMA) increase in nuclear ploidy and expression of the glycoproteins-IIIa and -Ib. Northern blot analysis revealed down-regulation of total GS-mRNA after treatment of DAMI-cells with TPO and PMA. Western blot analysis showed significant (P s-L with respective amounts of 27 ± 4% of total G s in untreated cells, 35 ± 1% in TPO- and 41 ± 3% in PMA-treated DAMI cells (n = 3-4). DAMI cells contained 6 ± 1 pmol cAMP/106 cells, which was not changed by treatment with TPO or PMA. In untreated cells this level increased to 70 ± 9 pmol cAMP/106 cells after 10 min stimulation with 1 μmol/l of the stable prostacyclin analog iloprost. The same stimulation with iloprost resulted in 165 ± 32 pmol cAMP/106 in TPO-treated cells and in 588 ± 100 pmol cAMP/106 in cells treated with PMA. Thus, a shift from Gsα-S to Gsα-L during megakaryoblast maturation strongly potentiates the production of cAMP. A similar shift may occur during normal megakaryocyte maturation and may explain the extreme sensitivity to prostacyclin of platelets, which contain Gsα-S and Gsα-L in approximately equal amounts.
- 1 September 1997
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (9) , 1830-1836
Signal Transduction Through Trimeric G Proteins in Megakaryoblastic Cell Lines
The biogenesis of trimeric G proteins was investigated by measurement of the expression of α-subunits in the megakaryoblastic cell lines MEG-01, DAMI, and CHRF-288-11, representing stages of increasing maturation, and compared with platelets. Megakaryoblasts and platelets contained approximately equal amounts of Giα-1/2, Giα-3, Gqα, and G12α protein. Maturation was accompanied by (1) downregulation of mRNA for Gsα and disappearance of iloprost-induced Ca2+mobilization, (2) upregulation of the long form of Gsα protein (Gsα-L) and an increase in iloprost-induced cAMP formation, and (3) upregulation of G16α mRNA and G16α protein and appearance of thromboxane A2-induced signaling (Ca2+mobilization and stimulation of prostaglandin I2–induced cAMP formation). Gzα protein was absent in the megakaryoblasts despite weak expression of Gzα mRNA in DAMI and relatively high levels of Gzα mRNA and Gzα protein in platelets. These findings reveal major changes in G protein–mediated signal transduction during megakaryocytopoiesis and indicate that G16α couples the thromboxane receptor to phospholipase Cβ.
- 1 September 1997
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (9) , 1830-1836
Signal Transduction Through Trimeric G Proteins in Megakaryoblastic Cell Lines
The biogenesis of trimeric G proteins was investigated by measurement of the expression of α-subunits in the megakaryoblastic cell lines MEG-01, DAMI, and CHRF-288-11, representing stages of increasing maturation, and compared with platelets. Megakaryoblasts and platelets contained approximately equal amounts of Giα-1/2, Giα-3, Gqα, and G12α protein. Maturation was accompanied by (1) downregulation of mRNA for Gsα and disappearance of iloprost-induced Ca2+mobilization, (2) upregulation of the long form of Gsα protein (Gsα-L) and an increase in iloprost-induced cAMP formation, and (3) upregulation of G16α mRNA and G16α protein and appearance of thromboxane A2-induced signaling (Ca2+mobilization and stimulation of prostaglandin I2–induced cAMP formation). Gzα protein was absent in the megakaryoblasts despite weak expression of Gzα mRNA in DAMI and relatively high levels of Gzα mRNA and Gzα protein in platelets. These findings reveal major changes in G protein–mediated signal transduction during megakaryocytopoiesis and indicate that G16α couples the thromboxane receptor to phospholipase Cβ.
- 1 January 1997
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 77 (01) , 143-149
Lateral Mobility of Integrin αIIbβ3 (Glycoprotein IIb/IIIa) in the Plasma Membrane of a Human Megakaryocyte
The migration of integrins to sites of cell-cell and cell-matrix contact is thought to be important for adhesion strengthening. We studied the lateral diffusion of integrin αIIbβ3 (glycoprotein Ilb/IIIa) in the plasma membrane of a cultured human megakaryocyte by fluorescence recovery after photobleaching of FITC-labelled monovalent Fab fragments directed against the P3 subunit. The diffusion of P3 on the unstimulated megakaryocyte showed a lateral diffusion coefficient (D) of 0.37 X10'9 cm2/s and a mobile fraction of about 50%. Stimulation with ADP (20 μM) or α-thrombin (10 U/ml) at 22° C induced transient decreases in both parameters reducing D to 0.21 X 10‘9 cm2/s and the mobile fraction to about 25%. The fall in D was observed within 1 min after stimulation but the fall in mobile fraction showed a lag phase of 5 min. The lag phase was absent in the presence of Calpain I inhibitor, whereas cytochalasin D completely abolished the decrease in mobile fraction. The data are compatible with the concept that cell activation induces anchorage of 50% of the mobile αIIbβ3 (25% of the whole population of receptor) to the cytoplasmic actin filaments, although, as discussed, other rationals are not ruled out.
- 1 January 1997
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 77 (01) , 143-149
Lateral Mobility of Integrin αIIbβ3 (Glycoprotein IIb/IIIa) in the Plasma Membrane of a Human Megakaryocyte
The migration of integrins to sites of cell-cell and cell-matrix contact is thought to be important for adhesion strengthening. We studied the lateral diffusion of integrin αIIbβ3 (glycoprotein Ilb/IIIa) in the plasma membrane of a cultured human megakaryocyte by fluorescence recovery after photobleaching of FITC-labelled monovalent Fab fragments directed against the P3 subunit. The diffusion of P3 on the unstimulated megakaryocyte showed a lateral diffusion coefficient (D) of 0.37 X10'9 cm2/s and a mobile fraction of about 50%. Stimulation with ADP (20 μM) or α-thrombin (10 U/ml) at 22° C induced transient decreases in both parameters reducing D to 0.21 X 10‘9 cm2/s and the mobile fraction to about 25%. The fall in D was observed within 1 min after stimulation but the fall in mobile fraction showed a lag phase of 5 min. The lag phase was absent in the presence of Calpain I inhibitor, whereas cytochalasin D completely abolished the decrease in mobile fraction. The data are compatible with the concept that cell activation induces anchorage of 50% of the mobile αIIbβ3 (25% of the whole population of receptor) to the cytoplasmic actin filaments, although, as discussed, other rationals are not ruled out.